The Secret Pharmacy Master Plan

Newsroom - InpharmD™

Newsroom - InpharmD™

Latest News

Submitted on November 02, 2023

Guidelines Updates for Opportunistic Infections in Adults with HIV

InpharmD's Monthly DI Corner – This month, we look at guideline updates on opportunistic infections in HIV ...

Submitted on September 29, 2023

Qlarant Capital Becomes Investor in InpharmD™

Qlarant Capital will work with InpharmD to ramp up the technology function via a new partnership

Submitted on September 29, 2023

Nirsevimab: A Promising Breakthrough in RSV Prevention

The approval of single-dose nirsevimab-alip offers extended protection against RSV

Submitted on September 21, 2023

Zuranolone: A Milestone in Postpartum Depression Treatment

Read about the safety and efficacy regarding the first FDA-approved oral medication for postpartum depression

Submitted on September 21, 2023

Therapeutic Potential of Metformin in Cirrhotic Patients with Diabetes

Exploring the Therapeutic Potential of Metformin in Cirrhotic Patients with Diabetes: Safety, Efficacy, and...

Submitted on June 13, 2023

How to Battle Misinformation in Pharmacy

Guest post written by Jake Galdo, PharmD, MBA, BCPS,

Submitted on June 13, 2023

SGLT2 Inhibitors — A New Solution for Heart Failure?

Commentary on the evolving role of SGLT2 inhibitors and their impact as a treatment for heart failure

Submitted on September 14, 2022

Saving Millions with Better Pharmacy Operations

Ashish Advani of InPharmD on Saving Hospitals Millions of Dollars

Submitted on February 23, 2022

InpharmD employs Kendra and Lex for evidence-based patient care enhancement

Sherlock employs Amazon Kendra for intelligent search and Amazon Lex for building conversational interfaces.

Submitted on February 23, 2022

Sherlock: The Drug Information Bot from InpharmD

Reliable, evidence-based drug information conferred by pharmacists and communicated via artificial intellig...

Submitted on April 02, 2021

Atlanta startup InpharmD uses AI to combat misinformation in the medical field

Tweets from the right influencers was all it took to skyrocket the interest and use of hydroxychloroquine a...

Submitted on February 24, 2021

PubMed is Drive Through Only Now

(and why we’re building on demand delivery)